Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Allergy, Asthma & Clinical Immunology
Published in: Allergy, Asthma & Clinical Immunology 2/2014

Open Access 01-12-2014 | Meeting abstract

Anti-Ige monoclonal antibody therapy for the treatment of chronic rhinosinusitis: a systematic review

Authors: Chris J Hong, Adrian C Tsang, Jason Quinn, James Bonaparte, Adrienne Stevens, Shaun J Kilty

Published in: Allergy, Asthma & Clinical Immunology | Special Issue 2/2014

Login to get access

Excerpt

Several treatment options are available for chronic rhinosinusitis (CRS), but disease control remains elusive for many patients. Recently, literature has emerged describing anti-IgE monoclonal antibody as a potential therapy for CRS. However, its effectiveness and safety are not well known. The purpose of this systematic review was three-fold: to assess the effectiveness and safety of anti-IgE monoclonal antibody therapy for the treatment of adult patients with CRS and to identify evidence gaps to guide future research on anti-IgE monoclonal antibody therapy for the management of CRS. …
Metadata
Title
Anti-Ige monoclonal antibody therapy for the treatment of chronic rhinosinusitis: a systematic review
Authors
Chris J Hong
Adrian C Tsang
Jason Quinn
James Bonaparte
Adrienne Stevens
Shaun J Kilty
Publication date
01-12-2014
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1710-1492-10-S2-A19

Other articles of this Special Issue 2/2014

Allergy, Asthma & Clinical Immunology 2/2014 Go to the issue

Meeting abstract

Treatment of angiotensin-converting enzyme inhibitor related angioedema with icatibant

Meeting abstract

Use of tiotropium bromide in an adolescent with adrenal suppression secondary to inhaled mometasone furoate

Meeting abstract

Tiotropium respimat® add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of TH2 inflammatory status

Meeting abstract

Type-III hereditary angioedema resolved by surgery

Meeting abstract

The prophylactic use of C1 esterase inhibitor in HAE patients undergoing invasive procedures

Meeting abstract

Epinephrine auto injector administration by parents or patients for anaphylaxis during supervised oral food challenges and assessment of confidence